How do you select bisphosphonate versus denosumab when initiating treatment prompted by opportunistic CT findings of low L1 attenuation and a prevalent vertebral fracture?
Roux et al., PMID 42961487
1 Answer
Mednet MemberInvited Expert
Rheumatology · University of Kansas
Answered on
Actually, I prefer calcitonin. It has few side effects and does not have the jaw necrosis risk.
Join for free or sign in to see the full answer